NASDAQ:AKU Akumin (AKU) Stock Forecast, Price & News $0.15 0.00 (0.00%) (As of 09/27/2023 ET) Add Compare Share Share Today's Range$0.14▼$0.1650-Day Range$0.13▼$0.2252-Week Range$0.12▼$2.18Volume857,811 shsAverage Volume620,160 shsMarket Capitalization$13.92 millionP/E RatioN/ADividend YieldN/APrice Target$0.25 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Akumin MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside63.4% Upside$0.25 Price TargetShort InterestHealthy3.80% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.96Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.22) to ($1.00) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.32 out of 5 starsMedical Sector361st out of 976 stocksMedical Laboratories Industry9th out of 24 stocks 3.0 Analyst's Opinion Consensus RatingAkumin has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.25, Akumin has a forecasted upside of 63.4% from its current price of $0.15.Amount of Analyst CoverageAkumin has only been the subject of 1 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted3.80% of the float of Akumin has been sold short.Short Interest Ratio / Days to CoverAkumin has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Akumin has recently decreased by 5.60%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAkumin does not currently pay a dividend.Dividend GrowthAkumin does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AKU. Previous Next 2.8 News and Social Media Coverage News SentimentAkumin has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Akumin this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for AKU on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Akumin to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Akumin insiders have not sold or bought any company stock.Percentage Held by Insiders20.51% of the stock of Akumin is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 36.10% of the stock of Akumin is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Akumin are expected to grow in the coming year, from ($2.22) to ($1.00) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Akumin is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Akumin is -0.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAkumin has a P/B Ratio of 0.12. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Akumin (NASDAQ:AKU) StockAkumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.Read More AKU Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AKU Stock News HeadlinesSeptember 14, 2023 | ca.finance.yahoo.comAkumin Inc. (AKU) Interactive Stock Chart - Yahoo FinanceAugust 10, 2023 | finanznachrichten.deAkumin Inc.: Akumin Announces Second Quarter 2023 Results, Revised FY23 Financial Outlook and Establishment of Special CommitteeSeptember 27, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.August 7, 2023 | finance.yahoo.com15 Worst Performing Tech Stocks in 2023August 2, 2023 | theglobeandmail.comClosing Bell: Akumin Inc down on Tuesday (AKU)June 19, 2023 | benzinga.comBragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, Phathom, and Akumin and Encourages Investors to Contact the FirmJune 12, 2023 | msn.comAkumin appoints Krishna Kumar as President and COOJune 12, 2023 | marketwatch.comAkumin Appoints Krishna Kumar to COO RoleSeptember 27, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.June 12, 2023 | finance.yahoo.comAkumin appoints President and Chief Operating OfficerMay 26, 2023 | benzinga.comAKUMIN ALERT: Bragar Eagel & Squire, P.C. is Investigating Akumin Inc. on Behalf of Akumin Stockholders and Encourages Investors to Contact the FirmMay 25, 2023 | benzinga.comKirby McInerney LLP Announces an Investigation of Shareholder Claims Against Akumin Inc. (AKU)May 17, 2023 | theglobeandmail.comClosing Bell: Akumin Inc flat on Tuesday (AKU)May 12, 2023 | marketwatch.comFriday Sector Laggards: Diagnostics, Auto DealershipsMay 12, 2023 | msn.comAkumin GAAP EPS of -$0.39, revenue of $187.59M in-lineMay 12, 2023 | finance.yahoo.comQ1 2023 Akumin Inc Earnings CallMay 11, 2023 | marketwatch.com10-Q: AKUMIN INC.May 11, 2023 | finanznachrichten.deAkumin Inc.: Akumin Announces First Quarter 2023 ResultsMay 10, 2023 | finance.yahoo.comAkumin Announces First Quarter 2023 ResultsMay 4, 2023 | finance.yahoo.comAkumin to Host First Quarter 2023 Financial Results Call on May 11, 2023April 22, 2023 | theglobeandmail.comClosing Bell: Akumin Inc up on Friday (AKU)April 18, 2023 | theglobeandmail.comClosing Bell: Akumin Inc flat on Monday (AKU)April 15, 2023 | theglobeandmail.comClosing Bell: Akumin Inc flat on Friday (AKU)April 13, 2023 | theglobeandmail.comClosing Bell: Akumin Inc flat on Thursday (AKU)April 13, 2023 | theglobeandmail.comClosing Bell: Akumin Inc up on Wednesday (AKU)March 17, 2023 | finanznachrichten.deAkumin Inc.: Akumin Announces Full-Year 2022 Results and Provides 2023 GuidanceMarch 15, 2023 | markets.businessinsider.comAkumin earnings: here's what Wall Street expectsSee More Headlines Receive AKU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter. Email Address AKU Company Calendar Last Earnings8/09/2023Today9/27/2023Next Earnings (Estimated)11/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AKU CUSIPN/A CIK1776197 Webwww.akumin.com Phone(844) 730-0050FaxN/AEmployees3,631Year FoundedN/APrice Target and Rating Average Stock Price Forecast$0.25 High Stock Price Forecast$0.25 Low Stock Price Forecast$0.25 Forecasted Upside/Downside+62.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($2.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-156,760,000.00 Net Margins-30.56% Pretax Margin-28.78% Return on Equity-167.86% Return on Assets-7.81% Debt Debt-to-Equity Ratio17.02 Current Ratio0.99 Quick Ratio0.99 Sales & Book Value Annual Sales$749.63 million Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book Value$1.24 per share Price / Book0.12Miscellaneous Outstanding Shares91,000,000Free Float72,334,000Market Cap$14.04 million OptionableNot Optionable Beta-0.68 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Riadh Zine-El-Abidine (Age 51)Chairman & CEO Comp: $1.78MMr. David Krestchmer (Age 65)Chief Financial Officer Comp: $580.51kMr. Rohit Navani (Age 46)Chief Corp. Affairs Officer Comp: $1.15MMr. Krishna Kumar AnanthasubramanianPres & COOMr. Paul Nelis (Age 55)Chief Information Officer Darren SpeedChief Compliance OfficerMs. Tracy Wiese (Age 54)Chief Strategy & Marketing Officer Ms. Holly Huso (Age 58)Enterprise Sales Officer Ms. Laurie R. Miller (Age 56)Chief HR Officer Mr. Mohammad SaleemSr. VP of Financial ReportingMore ExecutivesKey CompetitorsBioNexus Gene LabNASDAQ:BGLCPsychemedicsNASDAQ:PMDBioceptNASDAQ:BIOCCentogeneNASDAQ:CNTGTriSalus Life SciencesNASDAQ:TLSIView All CompetitorsInstitutional OwnershipBlackRock Inc.Sold 124,703 shares on 8/11/2023Ownership: 0.628%View All Institutional Transactions AKU Stock - Frequently Asked Questions Should I buy or sell Akumin stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akumin in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AKU shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AKU, but not buy additional shares or sell existing shares. View AKU analyst ratings or view top-rated stocks. What is Akumin's stock price forecast for 2023? 2 brokers have issued 12 month target prices for Akumin's shares. Their AKU share price forecasts range from $0.25 to $0.25. On average, they anticipate the company's share price to reach $0.25 in the next twelve months. This suggests a possible upside of 62.0% from the stock's current price. View analysts price targets for AKU or view top-rated stocks among Wall Street analysts. How have AKU shares performed in 2023? Akumin's stock was trading at $0.7188 at the beginning of 2023. Since then, AKU shares have decreased by 78.5% and is now trading at $0.1543. View the best growth stocks for 2023 here. Are investors shorting Akumin? Akumin saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 2,190,000 shares, a decrease of 5.6% from the August 31st total of 2,320,000 shares. Based on an average daily trading volume, of 1,650,000 shares, the short-interest ratio is currently 1.3 days. Approximately 3.8% of the company's shares are short sold. View Akumin's Short Interest. When is Akumin's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023. View our AKU earnings forecast. How were Akumin's earnings last quarter? Akumin Inc. (NASDAQ:AKU) posted its earnings results on Wednesday, August, 9th. The company reported ($0.60) EPS for the quarter. The firm earned $184.84 million during the quarter, compared to analysts' expectations of $193.50 million. Akumin had a negative trailing twelve-month return on equity of 167.86% and a negative net margin of 30.56%. What guidance has Akumin issued on next quarter's earnings? Akumin issued an update on its FY 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $740.00 million-$750.00 million, compared to the consensus revenue estimate of $781.75 million. What is Akumin's stock symbol? Akumin trades on the NASDAQ under the ticker symbol "AKU." Who are Akumin's major shareholders? Akumin's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (0.63%). How do I buy shares of Akumin? Shares of AKU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Akumin's stock price today? One share of AKU stock can currently be purchased for approximately $0.15. How much money does Akumin make? Akumin (NASDAQ:AKU) has a market capitalization of $14.04 million and generates $749.63 million in revenue each year. The company earns $-156,760,000.00 in net income (profit) each year or ($2.52) on an earnings per share basis. How many employees does Akumin have? The company employs 3,631 workers across the globe. How can I contact Akumin? The official website for the company is www.akumin.com. The company can be reached via phone at (844) 730-0050. This page (NASDAQ:AKU) was last updated on 9/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akumin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.